Organization: Health Canada
Year: 2022
Month: April
Request Number: A-2021-001603
Request Summary: For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the cover letter from the drug sponsor.
Disposition: All exempted
Number of pages: 0